Brought to you by 
SkyePharma buys the rest of RTP for $20.6mm
25 Apr 2002
Executive Summary
UK drug delivery company SkyePharma issued ordinary shares worth $20.6mm for 59.8% of RTP Pharma, a Canadian firm with technology that improves the water solubility of drugs. The purchase brings its ownership to 100%.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SkyePharma buys the rest of RTP for $20.6mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice